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Anthroyl ouabainNigella sativa seed oil was found to contain a modulator of Na,K-ATPase. Separation analyses combined
with 1H NMR and GCMS identiﬁed the inhibitory fraction as a mixture of oleic and linoleic acids. These two
fatty acids are speciﬁcally concentrated in several medicinal plant oils, and have particularly been implicated
in decreasing high blood pressure. The ouabain binding site on Na,K-ATPase has also been implicated in blood
pressure regulation. Thus, we aimed to determine how these two molecules modify pig kidney Na,K-ATPase.
Oleic and linoleic acids did not modify reactions involving the E1 (Na+) conformations of the Na,K-ATPase. In
contrast, K+ dependent reactions were strongly modiﬁed after treatment. Oleic and linoleic acids were found
to stabilize a pump conformation that binds ouabain with high afﬁnity, i.e., an ion free E2P form. Time-
resolved binding assays using anthroylouabain, a ﬂuorescent ouabain analog, revealed that the increased
ouabain afﬁnity is unique to oleic and linoleic acids, as compared with γ-linolenic acid, which decreased
pump-mediated ATP hydrolysis but did not equally increase ouabain interaction with the pump. Thus, the
dynamic changes in plasma levels of oleic and linoleic acids are important in the modulation of the sensitivity
of the sodium pump to cardiac glycosides. Given the possible involvement of the cardiac glycoside binding site
on Na,K-ATPase in the regulation of hypertension, we suggest oleic acid to be a speciﬁc chaperon that
modulates interaction of cardiac glycosides with the sodium pump.
Crown Copyright © 2011 Published by Elsevier B.V. All rights reserved.1. Introduction
The Na,K-ATPase (sodium pump) is a member of the P2-type
ATPase family, which includes gastric H,K-ATPase and sarcoplasmic
reticulum Ca2+-ATPase [1]. The Na,K-ATPase is a heterodimeric
membrane protein that pumps 3 Na+ ions out- and 2 K+ ions into
the cell, at the expenditure of the energy derived from hydrolysis of
one ATP molecule (Scheme 1). Consequently Na,K-ATPase establishes
an electrochemical gradient for these ions across the plasma
membrane, which is indispensible for many cell functions. The
enzyme consists of a catalytic α-subunit that undergoes ions- and
ATP-dependent conformational transitions coupling ATP hydrolysis to
ion transport, and a glycosylated β-subunit that is important for
function, folding, and plasma membrane delivery of the overall
enzyme complex [2]. The sodium pump also contains a highlyd; EP, phosphoenzyme; DMSO,
TCA, trichloroacetic acid
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11 Published by Elsevier B.V. All rigconserved site of inhibition by cardiac glycosides, which apparently
represents the molecular basis for the treatment of congestive heart
failure and supraventricular arrhythmias by these drugs formore than
200 years. The gastric H, K-ATPase is found in gastric parietal cells
where it exchanges cytoplasmic H+ for luminal K+, and is responsible
for a million fold H+ gradient across the epithelial cell membrane [3].
Traditionalmedicinehas beenawealthy sourceof chemotherapeutics
[4]. Several modulators of P-type pumps have also been found in
medicinal plants [5–7]. The seeds of Nigella sativa L. have traditionally
been used to treat several health problems. To date, about 6 active
principles have been isolated from the seed oil [8]. We have been
interested in identifying modulators of P-type ATPases in medicinal
plants (e.g., [9]). In this study, we have initially observed that an extract
of N. sativa seeds contains a factor that inhibits ATP hydrolysis by Na,
K-ATPase and H,K-ATPase. The active modulator was found to consist of
oleic and linoleic acids as the major components. Signiﬁcantly, the
predominant levels of these two fatty acids have been shown to build up
in the plasma of animals challenged with high salt intake [10].
Additionally, oleic acids have unambiguously been shown to have a
blood pressure lowering effect [11]. Furthermore, the highly conserved
cardiac glycoside site on the Na,K-ATPase has been implicated in the
regulation of blood pressure [12]. The above considerations motivatedhts reserved.
Scheme 1. Minimum reaction cycle of the Na,K-ATPase, according to the Post-Albers model [2].
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whereby oleic and linoleic acids modulate the properties of pig kidney
Na,K-ATPase. We provide evidence that an increase in the level of oleic
and linoleic acids in the membrane locks the sodium pump in a
potassium-free E2P conformation, the form that binds cardiac glycosides
with high afﬁnity.
2. Methods
2.1. Preparation and hydrolytic activity of Na,K-ATPase
Plasmamembranes frompig kidney red outermedullawere isolated
according to a modiﬁed Jørgensen's method described earlier [13]. In
brief, minced tissue pieces were homogenized in 30 mM imidazole
buffer pH 7.4, containing 250 mM sucrose and 1 mM EDTA. The
homogenate was subjected to several differential centrifugation steps
to obtain a microsomal plasma membrane fraction. Microsomes
were treated with a mild concentration of sodium dodecyl sulfate to
open sealed vesicles and dissociate several peripheral proteins
from the membrane. The ﬁnal preparation had a speciﬁc activity of
1.4–2.0 mmol.h−1.mg−1 protein at 37 °C. Protein concentration was
determined using a BioRad detergent compatible kit (Cat# 500–0113),
according to the manufacturer's instructions. ATPase activity was
measured by incubating the enzyme with buffer and substrates (see
separate ﬁgure legends) at 37 °C followed by measuring phosphate
liberated from ATP, according to the method of Baginsky [14]. Control
activities were measured in identical conditions but in the presence of
1 mMouabain. ATPase measurements made in the presence of low ATP
concentrations were performed in the presence of tracer amount of
32P-ATP. In the later case, ATP hydrolysis was determined bymeasuring
released
32
P, isolated after conversion to phosphomolybdate, essentially
as described earlier [15]. Para-nitrophenyl phosphatase (pNPPase)
activitywasmeasured in a reactionmixture containing 30 mMhistidine
pH 7.0, 5 mM MgCl, 10 mM para-nitrophenyl phosphate (pNPP), 5 μg
protein, and the K+ concentrations mentioned in the legend to Fig. 10.
Ouabain inhibitable para-nitrophenyl release was determined using a
colorimetric method, by measuring the absorbance at 410 nm. Para-
nitrophenyl has a molar extinction coefﬁcient of 1.8·104 M−1 cm−1.
2.2. Fractionation of the constituents of Nigella sativa L
The crude seed oil (13.7 g) was dissolved in methanol–water (9:1,
80 mL). The solution is extracted with petroleum ether (bp. 40–65 °C).
The two phases were separated and concentrated in vacuo. The residue
of the methanol–water phase was partitioned between water andtoluene (80 mL of each) and the obtained aqueous phase subsequently
extractedwith ethyl acetate.All four phaseswere concentrated in vacuo.
Only the toluene phase revealed a signiﬁcant activitywith respect to Na,
K-ATPase and H,K-ATPase inhibition. The residue of the toluene phase
(0.5 g) was fractionated by column chromatography over silica gel
(50 g) using toluene added 1% of acetic acid (400 mL), toluene-ethyl
acetate (19:1) added 1% of acetic acid (200 mL), toluene-ethyl acetate
(9:1) added 1% of acetic acid (400 mL), toluene-ethyl acetate (4:1)
added 1% of acetic acid (400 mL), toluene-ethyl acetate (3:2) added 1%
of acetic acid (200 mL). Fractions with a similar TLC proﬁle were
combined. Fractions eluting between 330 and 520 mL were combined
and concentrated in vacuo to give 357 mg of a residue. The residue
showed a signiﬁcant Na,K-ATPase and H,K-ATPase inhibitory activity.
The 1H NMR spectrum revealed that the residue was a mixture of oleic
acid and linoleic acid (1:1). GCMS after methylation with trimethylsilyl
diazomethane revealed the presence of methyl esters of oleic acid,
linoleic acid and a small amount of palmitic acid. Analytical grade free
fatty acids (N99%) were obtained from Sigma.
2.3. Phosphoenzyme measurements
Thephosphorylation reactionwasperformedbydiluting theenzyme
at 0 °C with 10-folds of an ice-cold solution. The ﬁnal phosphorylation
mixture contained 20 mM histidine pH 7.0, 0.2 mM EGTA, NaCl
(concentrations are mentioned in ﬁgure legends), 1 mM MgCl2, and
25 μMTris–ATP containing~20.000 cpm 32P-[ATP] per reaction. The acid
stable phosphoenzyme (EP) was quenched after 10 s with ice-cold
mixture containing5%TCA, 3 mMATP, and2 mMNa2HPO4, asdescribed
previously [16]. Phosphorylation in the presence of FFA was performed
by pre-incubating the enzymewith FFA for 5 min at room temperature
(either in the absence or in the presence ofNa+), followed by chilling on
ice for fewminutes prior to phosphorylation start. The EP was collected
by centrifugation and its radioactivity determined using scintillation
counting. Data were expressed as EP phosphoenzyme formed in the
presence of NaCl minus that formed in the presence of KCl (replacing
NaCl). All phosphorylation data are presented as mean±s.e.m. of
triplicate measurements. Phosphorylation from inorganic phosphate
was performed by incubating the enzyme for 15 min at room
temperature in the same buffer but in the presence of 6 mM MgCl2
and 40 μM Na2HPO4 containing ~20.000 cpm 32P.
2.4. Assay for K+ occlusion
K+ occlusion was measured by simple gel ﬁltration method [17]
using 5 cm plastic columns loaded with Dowex 50WX8, which were
Fig. 1. Components in N. Sativa that inhibit K transporting P-type pumps are oleic and
linoleic acids. A. For pig kidney Na,K-ATPase (squares and circles) the ATPase reaction
contained 20 mM Histidine pH 7.0, 100 mM NaCl, 20 mM KCl, 3 mM ATP, 3 mM MgCl2,
5 μg protein, and the indicated volumes of oil (producing a ﬁnal dilution ranging from 0 to
0.003, vol/vol). The DMSO concentration was kept constant at 2% in all samples by
supplementationwith DMSO. For pig stomachH,K-ATPase (triangles) the ATPase reaction
contained 5 μg pig gastric mucosal membranes and NaCl was omitted. Alamethicin
(1.25 μg.ml−1) was also present in the mixture to increase the permeability of the gastric
mucosal vesicles. Circles depict a similar inhibition by diluted oil of Na,K-ATPase
solubilized with the nonionic detergent C12E10 (0.5 mM). This concentration is enough
for complete solubilization of the membranes, as estimated from separate experiments in
which the detergent-induced drop in light absorption at 220 nm (indicative of membrane
solubilisation)wasmeasured. Controlswere also performed inwhichNa,K-ATPase activity
wasmeasured in the presence of 1 mMouabain (Na,K-ATPase) or in the absence of KCl (H,
K-ATPase) and in the presence of N-methyl glucamide (NMG). B. The ATPase reaction
contained 20 mM Histidine pH 7.0, 100 mM NaCl, 20 mM KCl, 3 mM MgCl2, 3 mM ATP,
5 μg protein, and the indicated concentrations of oleic acid (circles) or linoleic acid
(triangles). The EC50 of inhibition, calculatedbyﬁtting aHill-equation [Y=bottom+(top–
bottom)/(1+10((log EC50−x)Hillslope))] to the data, was 24.4±1.12 μM (Hill slope=
−1.089±0.14) and 49.7±3.2 μM(Hill slope=−1.27±0.18) for oleic- and linoleic acids,
respectively. Note that FFA concentrations are plotted on a logarithmic scale.
Fig. 2. Effect of linoleic acid on ATP activation of the Na,K-ATPase. The ATPase reaction
contained 20 mMHistidine pH 7.0, 100 mMNaCl, 20 mMKCl, 3 mMMgCl2, 5 μg protein,
and the indicated ATP concentrations, either in the absence (squares) or in the presence
(circles) of 25 μM linoleic acid. Controls were performed in which Na,K-ATPase activity
wasmeasured in the presence of 1 mMouabain. The data were analyzed usingMichael–
Menten equation, giving a K0.5 of 336.6±47.4 μM and 39.5±4.8 μM for the control and
linoleic acid treated enzyme.
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200 μg Pig kidney Na,K-ATPase was incubated for 10 min at room
temperature in a buffer containing 150 mM Tris, pH 7.0, 1 mM RbCl2
(containing 2.2 . 105 cpm 86Rb). Following incubation with Rb+,
either DMSO or 100 μM FFA (total volume 80 μl) was added and the
mixtures were incubated for further 10 min. The reactions were then
quenchedwith 420 μl ice cold 200 mM sucrose and themixtures were
transferred to cold room. 200 μl of the occlusion mixture was loaded
on the columns. Unbound Rb+ was removed and protein with bound
86Rb+ was eluted by passing 1300 μl of 200 mM sucrose through the
column. Eluted proteins were counted in scintillation counter. Control
experiments were performed to make sure that more than 95% of the
protein was eluted from the column.
2.5. Measurements of anthroylouabain ﬂuorescence
A SPEX Fluorolog-3 spectroﬂuorometer equipped with a
thermostated cell compartment and a magnetic stirrer was used to
measure the kinetics of ouabain interaction with the Na,K-ATPase, as
previously described [18]. The excitation wavelength was 370 nm
(band pass 5 nm). The emission wavelength was 485 nm (band pass
14 nm). The buffer in the Cuvettes contained 20 mM Tris-buffer pH
7.0, 2 mM MgCl2, 4 mM HPO4, 50 μM free fatty acid, and 1 μM
anthroylouabain. The enzyme was treated with free fatty acid for
15 min at room temperature in the presence of 20 mM Tris, pH 7.0,
4 mM HPO4 and 2 mM MgCl2 (a condition favoring formation of the
E2P form). Time-resolved ﬂuorescence increase, indicative of ouabain
interaction with the Na,K-ATPase, was measured upon addition of the
incubated enzyme to anthroylouabain-containing buffer. ATPase
assays demonstrated similar inhibition of the pig kidney Na,K-ATPase
by anthroyl ouabain and ouabain.
2.6. Data analysis
All experiments were repeated at least two times, and all
measurements are performed at least in duplicates. Data were plotted
as mean±s.e.m. of three independent measurements.
3. Results
3.1. Nigella sativa seed extract contains a factor that inhibits K+ transporting
P2-type pumps
Addition of N. sativa seed oil to ATPase assays resulted in
signiﬁcant inhibition of the hydrolytic activity of pig renal medulla
Na,K-ATPase and pig stomach H,K-ATPase (Fig. 1A). An inhibition of
Na,K-ATPase was also obtained after complete solubilization of the
membranes with the non-ionic detergent C12E10. This indicates that
themixture contains components(s) that interact speciﬁcally with the
protein, with no contribution from bulk lipids in themembrane to this
interaction, as is the case with Na,K-ATPase inhibitors such as
curcumin [19].
The crude oil constituents were separated onto three organic
phases, of which the toluene phase was found to contain the
inhibitory fraction. Constituents in the toluene phase were separated
by column chromatography and 10 fractions were further obtained.
Three successive fractions (F2, F3, and F4) contained the inhibitor. 1H
NMR and GCMS characterization of fraction 3 revealed that the
inhibitory principle in N. sativa is a 1:1 mixture of oleic and linoleic
acids. Subsequently, Fig. 1B demonstrates the inhibition by analytical
grade oleic and linoleic acids of puriﬁed pig kidney Na,K-ATPase. With
the observed difference in EC50 (see legend to Fig. 1B), oleic acid was a
more effective inhibitor than linoleic acid. Indeed, free fatty acids have
previously been shown to inhibit the activity of crude preparations of
brain Na,K-ATPase (e.g., [20,21]). Because of the lack of detailed
analysis on which step in the reaction cycle is affected by free fattyacids, the following experiments were performed to understand the
effect of these fatty acids on the kinetic properties of pig kidney Na,
K-ATPase, containing the α1 isoform as the main catalytic subunit, in
addition to the β1 isoform [22].
Treatmentwith 25 μMlinoleic acid resulted in a signiﬁcant three fold
decrease in the apparent afﬁnity of the enzyme for K+ (the K0.5 for K+
was 0.81±0.09 mM and 2.58±0.31 mM for the control and linoleic
acid treated enzyme, respectively). On the other hand, the apparent
afﬁnity for Na+was not signiﬁcantly changed following treatmentwith
linoleic acid (the K0.5 for Na+ was 13.35±1.21 mM and 15.95±
2.54 mM for the control and linoleic acid treated enzyme, respectively).
Interestingly, a distinct effect on the activation of Na,K-ATPase by ATP
was found (Fig. 2). Thus, linoleic acid stimulatedNa,K-ATPase activity at
limited ATP concentrations and an inhibition was evident at ATP
concentrations N300 μM. Oleic acid behaved in a similar way.
Fig. 4. Effect of oleic and linoliec acid on vanadate inhibition of Na,K-ATPase. ATPase
activity was measured in the presence of 20 mM Histidine pH 7, 130 mM NaCl, 20 mM
KCl, 1.2 mM ATP, 3 mMMgCl2, 5 μg protein, and the indicated vanadate concentrations.
Data were analyzed using the Hill equation, which gave a EC50 for vanadate inhibition of
0.51±0.02 μM for the control (squares), 1.81±0.03 μM after treatment with 25 μM
oleic acid (circles), and 4.24±0.03 μM after treatment with 25 μM linoleic acid
(triangles). Data are expressed as percentage of control, measured in the absence of
FFA. Speciﬁc Na,K-ATPase activity is deﬁned as the difference between the sample and
an identical sample measured in the presence of 1 mM ouabain. Note that vanadate
concentrations are plotted on a logarithmic scale.
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Results in Fig. 3 demonstrate how the inhibitory potency of linoleic
acid is affected by substrates of the Na,K-ATPase. The EC50 of inhibition
by linoleic acid strongly increased following the addition of K+
(Fig. 3A), consistent with a decreased interactionwith Na,K-ATPase by
increasing K+ concentration, in a competitive manner. On the other
hand, Na+ was found not to signiﬁcantly affect the inhibition by FFA,
either in the presence (Fig. 3B) or in the absence (not shown) of K+. In
the absence of K+, increasing concentrations of ATP resulted in a
further decrease in the EC50 of inhibition by FFA, consistent with
increased interaction with the ATPase facilitated by ATP (Fig. 3C).
Hence, K+ represents the major substrate that controls the potency of
interaction of FFAwith the Na,K-ATPase. Similar results were obtained
following treatment with oleic acid (data not shown).
3.3. Oleic and linoleic acids compete with vanadate for Na,K-ATPase
We have investigated the effect of FFA on the inhibition by the
transition state inorganic phosphate analog vanadate [23] which
interacts preferentiallywith the E2 forms of the enzyme. As depicted in
Fig. 4, the effect of oleic and linoleic acids on the vanadate inhibition of
Na,K-ATPase is shown. Treatmentwith FFA strongly increased the EC50
for vanadate inhibition, consistent with a decreased vanadate
interaction with the Na,K-ATPase. Thus, ﬁtting a Hill equation to the
data revealed that oleic and linoleic acids increased the EC50 for
vanadate inhibition by 4 and 8 folds, respectively (EC50 was 0.51±
0.04, 1.92±0.06, and 3.49±0.53 μM for the control, oleic acid, and
linoleic acid treated Na,K-ATPase, respectively).
3.4. Linoleic acid increases K+-deocclusion under conditions of limiting
ATP concentrations
Wehavemeasured the effect of increasing concentrations of K+ on
Na-ATPase activity in the presence of low concentrations of Na+ and
ATP, two substrates that induce transition to the E1 form when
present in high concentration [23]. Under this conditions, the E2→E1
conformational transition is rate limiting and addition of K+ inhibits
Na-ATPase activity of the control enzyme as a consequence of
accumulation of K+-occluded enzyme, E2(K2). A typical result is
demonstrated in Fig. 5. As seen, addition of K+ to Na-ATPase assays
containing 20 mMNa+ and 10 μMATP resulted in concomitant loss of
Na-ATPase activity of the control enzyme (squares). Transition of the
E2 form to E1 and restoration of K+ dependent ATPase activity at low
ATP concentrations, indicative of an increase in the rate of ATP-
independent K+ deocclusion, has been observed following treatmentFig. 3. The effect of substrates on EC50 of inhibition by linoleic acid. Several linoleic acid in
inhibition was calculated in each case using The Hill equation. The ATPase reactions contai
concentrations ranging from 0 to 100 μM. All reactions were measured at 37 °C. A. Inhibition
K+ concentrations (as indicated in the inset to panel A). The corresponding EC50 for inhibitio
performed in the presence of 10 mM KCl and the indicated ﬁxed Na+ concentrations. The co
C. Inhibition by linoleic acid was performed in the absence of K+ and in the presence of
inhibition was calculated and plotted against ATP concentration.with linoleic acid (circles). This indicates that the K+-occluding
enzyme conformer that is stabilized by the presence of K+ in the case
of the control enzyme is destabilized in the presence of linoleic acid,
allowing for transition to the E1 form, phosphorylation from ATP, and
hence net increase in ATP hydrolysis occurs.3.5. Oleic and linoleic acids do not modify cytoplasmic K+ antagonism
In an attempt to unravel the effect of oleic and linoleic acids on the
kinetic properties of Na,K-ATPase, we have investigated the effect
of these FFA on the inhibition by K+ of cytoplasmic Na+ interaction.
Indeed, earlier studies have outlined cytoplasmic K+ antagonism as
an important pump regulatory mechanism [24]. Under physiological
conditions K+ competes with Na+ for the intracellular ion binding sites
as the intracellular concentration of K+ is several fold that of Na+.
Performing Na+ activation curves in the presence of different ﬁxed
K+ concentrations can provide information on how the apparent Na+
afﬁnity changes with increasing K+ concentrations. As demonstrated
previously [25], a linear relation between the calculated apparent Na+
afﬁnities and the K+ concentration is expected from which the K+
inhibitiondissociation constant, KK, canbedetermined.No change in the
K+/Na+ antagonismwas observed after treatmentwith oleic or linoleic
acids (data not shown).hibition curves were performed in the presence of different additions and the EC50 for
ned 20 mM histidine pH 7, 3 mM MgCl2, 5 μg pig kidney membranes, and linoleic acid
by linoleic acid was performed in the presence of 100 mM NaCl and the indicated ﬁxed
n was calculated and plotted against K+ concentration. B. Inhibition by linoleic acid was
rresponding EC50 for inhibition was calculated and plotted against Na+ concentration.
100 mM Na+ and the indicated ﬁxed ATP concentrations. The corresponding EC50 for
Fig. 5. ATPase assay for measuring K+-deocclusion. ATPase activity was measured in a
reaction assay containing 20 mM histidine pH 7, 3 mM MgCl2, 10 μM Tris-ATP
(containing 105 cpm 32P-ATP), 20 mM NaCl, 5 μg protein, and the indicated K+
concentrations. The reactions were performed in the presence of either DMSO
(squares) or 25 μM linoleic acid (circles). Following incubation of the enzyme with
substrates the reactions were terminated with acid and the ouabain-inhibitable 32P
produced from 32P-ATP hydrolysis was separated as phosphomolybdate on organic
phase and counted, as described in Methods. Note that treatment with linoleic acid
decreased Na-ATPase by almost 50%.
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Ouabain is a highly speciﬁc inhibitor of the Na,K-ATPase that binds
with high afﬁnity to the E2P form [26] and with lower afﬁnity in the
presence of K+ [27]. We have established that linoleic acid increases
the inhibition by ouabain of Na,K-ATPase (Fig. 6), thus, treatmentwith
30 μM linoleic acid increased the ouabain afﬁnity by approximately
four fold compared to untreated control (see legend to Fig. 6). A
similar result was obtained after treatment with oleic acid (data not
shown).
3.7. Oleic and linoleic acids do not affect steady state levels of the E1P or
the E2P forms
We have studied the effect of FFA on phosphorylation of the pump
from ATP. Addition of MgATP to enzyme pre incubated in the presence
of Na+ (E1 form) results in phosphoryl transfer and formation of E2P
through the reaction E1→E1P→E2P. However, if theNa+ concentration
is high, the transition of E1P to E2P will be restricted and the dominant
phosphorylated species will be E1P. Hence, phosphorylation reactions
performed in the presence of saturating or super saturating Na+
concentrations will give information on the steady state E2P or E1PFig. 6. Effect of linoliec acid on the apparent afﬁnity for ouabain. ATPase activity was
measured in the presence of 20 mM Histidine pH 7.0, 100 mM NaCl, 20 mM KCl, 3 mM
ATP, 3 mM MgCl2, 5 μg protein, and the indicated ouabain concentrations. Data were
analyzed using a Hill equation, which gave an EC50 for ouabain inhibition of 19.42±
1.08 μM for control (squares), 13.1±1.05 μM, 8.58±1.05 μM, and 5.03±1.04 μM, after
treatment with 5 μM (circles), 15 μM (triangles) or 30 μM (diamonds) linoleic acid,
respectively. The Hill slopewas between−1.0 and−1.2 in all cases. Data are expressed as
percentage of control, measured in the absence of the linoleic concentration used. Note
that ouabain concentrations are plotted on a logarithmic scale. Oleic acid increased
ouabain afﬁnity in a similar way.levels, respectively. Treatmentwith oleic and linoleic acids did not affect
conformational transitions involving either form (data not shown).3.8. Oleic and linoleic acids increase phosphorylation from inorganic
phosphate in the absence of K+ but phosphorylation is decreased in its
presence
We have studied the effect of FFA on phosphorylation of the pump
from inorganic phosphate, which occurs in the absence of alkali metal
ions and in the presence of Mg2+, the so called backdoor phosphor-
ylation. Several studies have indicated the presence of at least two
different E2P variants [28–30], probably reﬂecting the order of ligand
binding to the enzyme and the rate of inter conversion between the
different isomers. In the absence of K+, treatment with oleic or
linoleic acid resulted in a signiﬁcant increase in the steady state EP
level (Fig. 7A), demonstrating that an ion free phosphoenzyme is
stabilized by treatment (see Discussion). This effect is indeed very
similar to that of ouabain [31].
Major E2P phosphoforms include ion free E2P as well as K+ bound
E2P(2 K+). It was of interest to investigate the effect of oleic and linoleic
acids on EP level measured in the presence of 20 mM K+, i.e., a
phosphoenzyme fraction that simultaneously binds K+ and phosphate
[28]. Thus, when the experiments in Fig. 7A were repeated under the
same conditions but in the presence of 20 mM K+, the steady state
phosphoenzyme level was only 25% of that measured in the absence of
K+, in excellent agreementwithprevious studies (see Fig. 8 inRef. [28]).
Interestingly, oleic and linoleic acids strongly decreased steady state EP
level in the presence of K+ (Fig. 7B). Since the proposed E2P(2 K+) form
binds K+ and inorganic phosphate simultaneously, it is likely that the
decrease in the steady state phosphoenzyme seen after treatment with
FFA is a consequence of K+ release from the enzyme.3.9. Oleic and linoleic acids decrease K+ afﬁnity of pNPPase without
effect on maximum pNPPase activity
Na,K-ATPase catalyzes Mg2+-dependent K+-activated hydrolysis of
pNPP. pNPP hydrolysis is catalyzed by a K+-occluded enzyme and
proceeds without enzyme phosphorylation [32,33]. We have studied
the effect of FFA on the activation by K+ of pNPP hydrolysis. As seen in
Fig. 8A, oleic and linoleic acids increased the K+ concentration required
to obtain half maximum activation of pNPPase. As shown in Fig. 8B, FFA
concentrations up to 100 μM did not signiﬁcantly modulate pNPPase
activity in the presence of 150 mM K+.Fig. 7. Phosphorylation from inorganic phosphate. 0.1 mg of pig kidney Na,K-ATPase
was incubated in a phosphorylation reaction buffer containing 20 mM histidine, pH 7.0,
0.1 mM EGTA, 6 mM MgCl2, 20 mM of either NMG (A) or KCl (B), and 100 μM of either
DMSO (control) or free fatty acid, as indicated. The reaction was started with the
addition of 32P mixture producing 40 μM Na2HPO4 as well as 4.7·105 cpm 32P per
reaction. The reaction was allowed to proceed for 15 min at room temperature and
terminated with the addition of acid.
Fig. 8. Effect of FFA on K+ dependent phosphatase activity, pNPPase. pNPPase activity
was measured in a reaction mixture containing 30 mM histidine pH 7, 10 mM pNPP,
20 mM MgCl2, and 10 μg protein. The reactions were started with the addition of
enzyme (37 °C) and terminated with trichloroacetic acid (TCA). pNP produced from
hydrolysis of pNPP was measured by a colorimetric method, as described in Methods.
A. Effect of oleic and linoleic acids on the activation by K+ of pNPPase. The K0.5 values for
K+ activation were calculated by ﬁtting a sigmoid dose response function to the data,
which were 2.56±1.26 mM, 5.59±1.33 mM and 11.62±1.23 for the control, oleic acid
treated- and linoleic acid treated membranes, respectively. B. The effect of different
concentrations of oleic (squares) and linoleic (triangles) acids on pNPPase measured at
150 mM KCl.
Fig. 10. Determination of the Na+ afﬁnity for phosphorylation starting from the E2-FFA
complex. 200 μg of pig kidney enzyme was incubated with histidine buffer in order to
stabilize the E2 conformation, and DMSO or FFA was added. Following 5 min incubation
at room temperature the enzyme was then mixed with ice-cold phosphorylation buffer
for 15 s before acid quenching. The reaction contained (ﬁnal concentrations) 1 mM
MgCl2, 25 μM ATP (containing 2.106 cpm P32-[ATP]) and the indicated Na+ concentra-
tions. A. Control enzyme (squares) is compared with enzyme treated with 50 μM oleic
acid (circles). B. Control enzyme (squares) is compared with enzyme treated with
50 μM linoleic acid (triangles). Data ﬁtting using a hyperbolic equation gave a K0.5 for
Na+ of 7.85±1.14 mM, 2.6±0.37 mM and 2.42±0.34 for the vehicle-, oleic acid-, and
linoleic acid-treated samples, respectively.
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We have measured the effect of oleic and linoleic acids on K+
occlusion using a direct binding assay. Both oleic acid and linoleic acid
was found signiﬁcantly decreased the amount of 86Rb+ eluted with
the protein (Fig. 9), demonstrating that these fatty acids stabilize an
Rb+ free conformer.
3.11. Oleic and linoleic acids increase the Na+ afﬁnity for phosphorylation
of the E2-FFA complex
Membrane-bound enzyme is known to adopt an E2 conformation
when present in histidine-EDTA buffer in the absence of substrate ions
[34]. Transition to the E1 form requires the addition of Na+. However,
in the presence of drugs stabilizing an E2 conformation, more Na+ has
to be added to induce transition to the E1 conformer and subsequent
phosphorylation fromATP, and this would appear as an increase in the
Na+ concentration required to obtain half-maximumphosphoenzyme
level, i.e., a decrease in the afﬁnity of the enzyme for cytoplasmic Na+.
As seen in Fig. 10, oleic and linoleic acids were unexpectedly found to
signiﬁcantly increase the phosphoenzyme level measured as a
function of Na+ concentration. This result, ironically indicating a
shift to the E1 form, occurs onlywhen the enzymewas pre treatedwith
the fatty acid prior to the addition Na+.Fig. 9. Effect of oleic and linoleic acids on Rb+ occlusion. Membrane bound Na,K-ATPase
was incubated with 86RbCl as described in Methods. Membranes with bound Rb+ were
separated from bulk ions by passing through Dowex50 column. 86Rb+ eluted from the
column in the absence of the protein (usually less than 10–25% of total) was subtracted
from that measured in its presence. 2 μl from the occlusion mixture was counted and
used to calculate the 86Rb+ occlusion in nmol.mg−1 protein.3.12. Effect of fatty acids on anthroylouabain interaction with the Na,K-
ATPase
Different fatty acids are likely to have differential effects on the
kinetic properties of theNa,K-ATPase. Previous studies have particularly
implicated oleic and linoleic acids in the regulation of blood pressure
[10,11]. The fact that other medically important plant oils contain high
levels of oleic and linoleic, but not other fatty acids, motivated us to
compare the effect of oleic and linoleic acids with that of linolenic acid,
which is identical in chain length but contains additional unsaturation at
C15. ATPase assays can be used to gain information on steady state
binding of the cardiac glycosides (Fig. 7) occurring following incubation
with the drug for several minutes. However, time resolved studies
would be more appropriate for comparison. Hence, we measured
anthroylouabain binding toNa,K-ATPase treatedwith oleic (C18, cis-Δ9),
linoleic acids (C18, cis, cis-Δ9, Δ12), and γ-linolenic (C18, cis, cis, cis -Δ9,
Δ12, Δ15). Both anthroylouabain and ouabain inhibit the Na,K-ATPase
with a similar potency in ATPase assays (Supplementary Materials). As
seen in Table 1, treatmentwith oleic acid resulted in a robust increase in
the rate constant of ﬂuorescence increase (i.e. anthroyl ouabain
binding), which was about three fold than that of control. Linoleic acid
produced a similar two fold increase in the rate constant. In contrast,
γ-linolenic acid had no effect on the rate constant of ouabain binding.
Apparently, unsaturation at C9 is important in ouabain interaction, and
additional unsaturation reduces the effect.Table 1
Effect of fatty acids on the rate of anthroylouabain binding.
Anthroyl ouabain ﬂuorescence was measured as described in Methods. Enzyme
stabilized in the E2P formwas treated with DMSO, oleic acid, linoleic acid, or γ-linolenic
acid. The fatty acid concentration was 50 μM. Anthroyl ouabain ﬂuorescence was
measured as a function of time following addition of the incubated enzyme into
anthroyl ouabain containing cuvette. The rate constants for anthroyl ouabain
interaction were obtained by ﬁtting a mono exponential function to the data.
Fatty acid Rate constant for anthroylouabain binding (s−1)
DMSO 0.0081±8.6·10−5
Oleic 0.0271±5.3·10−4
Linoleic 0.0155±2.1·10−4
Linolenic 0.00890±1.27·10−4
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4.1. FFA treatment increases the number of static pump units in the
membrane
In this study, we ﬁrst identiﬁed the active principle that modulates
K+-transporting P-type ATPases in N. sativa and we showed that oleic
and linoleic acids inhibition is ascribed to stabilization of an E2 variant,
possibly identical with the E2P form that binds ouabain with high
afﬁnity. An interesting inquiry is why a speciﬁc fatty acid molecule,
which inhibits the pump, facilitates interaction with another inhibitor
to the pump? It is now well accepted that a fraction of inactive Na,
K-ATPase is present in the plasmamembranes of some cells, which can
signiﬁcantly reach up to 50%of total pumps [35]. The inactive pumps are
believed to bind ouabain with high afﬁnity and to participate in several
signaling cascades [36,37]. Indeed, the effect of fatty acid and ouabain is
additive, suggesting that the twomolecules bind at different sites on the
pump. The crystal structure of the pump with bound ouabain [38]
revealed that the cardiac glycoside is well inserted between transmem-
brane domains. Oleic or linoleic acids conceivably interact at the lipid
protein interface, alternating between bulk and annulus lipids shells in
the membrane. Hence, the fatty acid likely synergizes the interaction of
ouabain with Na,K-ATPase.
The inhibitory effect of long chain fatty acids on crude brain
membranespublished earlier [20,21] is generally in agreementwith this
study. However, somediscrepancies are apparent thatmay be related to
the fact that pNPPase (which does not phosphorylate the pump) rather
than ATPase activity was used to determine substrate afﬁnity [21]. In
addition, brain tissue is known to contain three different Na,K-ATPase
isoformsandalso contains lipidswith thehighestdegreeof unsaturation
among organs.
4.2. Oleic and linoleic acidmodulation of pump conformation and substrate
interaction
At low ATP concentrations, the activity of the FFA treated enzyme
is higher than that of the untreated enzyme, as a consequence of
increased rate of spontaneous K+ deocclusion. The competition of FFA
with the inhibition by vanadate (Fig. 4) together with the facilitation
of K+ release (Fig. 5) indicate that FFA interferes with ATP interaction
at the regulatory site on the enzyme [39,40], resulting in signiﬁcant
reduction in net ATP hydrolysis occurs (Fig. 1B). FFA strongly
increases the level of phosphorylation from inorganic phosphate in
the absence of K+, indicating stabilization of the K+ free E2P form by
FFA interaction (Fig. 7). That FFA decreases extracellular K+ binding to
the E2P form by closing or shielding the extracellular sites is less likely,
as it will imply a decrease in the apparent afﬁnity for ouabain.
Addition of MgATP to enzyme pre equilibrated with Na+ (E1 Na+)
results in phosphorylation from ATP and formation of a mixture of both
E1P and E2P, depending on the Na+ concentration present in the
medium [41]. Treatmentwith oleic or linoleic acids of enzyme stabilized
in the E1 Na+ form did not affect steady state phosphoenzyme level
(data not shown). However,when the enzyme is equilibratedwith oleic
or linoleic acid prior to the addition of Na+ and MgATP, a signiﬁcant
increase in phosphoenzyme level was observed (Fig. 10), which is
consistent with an increase in the afﬁnity for Na+ at the high afﬁnity
cytoplasmic sites. This and the aforementioned result are interesting
and may be interpreted by considering the half-site reactivity model of
the pump ([42] and references therein). Half of the pumps are believed
to adopt an E1 conformation in the presence of Na+ and be
phosphorylated from ATP. On the other hand, incubation with the
fatty acid (before the addition of Na+) likely shifts the conformational
equilibrium of pumps toward E2. Na+ binding to extracellular sites in
the fatty acid-bound E2 conformers results in transition to the E1 and
allows ahigher EP level. Hence, under the experimental conditions used,
the observed increase in the apparent Na+ afﬁnity for phosphorylationafter FFA treatment is likely a consequence of the increased initial level
of the E2 induced by fatty acid treatment. The effect of fatty acid may
thus be related to the dissociation of diprotomeric (α·β)2 forms into
protomeric (α·β)1 forms. Indeed, a tenfold increase in the rate constant
for formation of the E2P state from dephosphorylated kidney enzyme
was observed upon dissociation of diprotomers into protomers [43].
Free fatty acids have a pKa of about 5. Thus, fatty acid anions are
expected to be the dominant species at neutral pH. Fatty acid anions are
amphiphilic and possibly function by attacking protein–protein in-
teractions in the membrane, lending further evidence to the above
mentioned explanation. It is noteworthy that both oleic and linoleic
acids induce differential effects on the kinetic properties of the pump.
Hence, The EC50 for inhibition of ATPhydrolysis is lower for linoleic acid,
yet linoleic acid produces a stronger shift in the vanadate inhibition
curve.
N. sativa is characterized with a high content (approximately 20%)
of free fatty acids [44]. In all monographs of the European
Pharmacopeia plant, oils are to be tested for the level for FFA to
ensure that the oil is not rancid. The oil of N. sativa is not included in
the pharmacopeia, but the level signiﬁcantly exceeds the level
generally stated for plant oils. It is noteworthy that other medicinal
plant oils have been shown to contain impressive distribution of
essential free fatty acids, with oleic and linoleic acids representing the
major part. Thus, the content of free fatty acids in Argan oil is around
80%. Of these, oleic acid and linoleic acid represents 42.8% and 36.8% of
total, respectively, whereas the content of linolenic acid is less than
0.5% [45]. In studies aiming at identifying speciﬁc drugs to P-type
pumps from natural sources, it is necessary to ﬁrst separate the
(apparently standard) fatty acid component from other constitutes.
4.3. Regulation of membrane transport proteins by direct interaction
with lipids
Interaction of lipids with regulatory sites on membrane proteins is
now recognized as a potential mechanism of membrane protein
modiﬁcation [46]. A typical example is the regulation by phosphatidyl
serine of K+ channels. Themechanism of regulation is based on amodel
in which the negative head group of the lipid resides on a cluster of
membrane adjacent positively charged residues in the protein located
close to the inner face of the plasma membrane [47]. The regulation by
FFA ofmembrane proteinsmay operate by a similarmechanism. In type
2 diabetes patients, total plasma FFA concentrations are signiﬁcantly
elevated [48,49] and this could challenge the buffering capacity of
plasma membrane proteins. Hence, transient or sustained increase in
the concentration of FFA can contribute directly to signiﬁcant effects on
the Na,K-ATPase and other membrane transport proteins. Under
physiological conditions, and considering only the effect of oleic and
linoleic acids on Na,K-ATPase, we would imagine that treatment with
the fatty acid will lead to K+ release back to the interstitial space due to
the abolishment of low afﬁnity ATP interaction, resulting in an increase
in the extracellular concentration of K+.
4.4. Do speciﬁc fatty acids act as chaperons for Na,K-ATPase?
It is now well accepted that endogenous ouabain plays a
substantial role in cell physiology [50]. The ouabain binding site of
the Na,K-ATPase has been shown to be important in blood pressure
regulation [12]. The same function has been allocated to dietary oleic
acid [11]. The signiﬁcant and speciﬁc effect of oleic acid on interaction
of ouabain with the Na,K-ATPase may allow us to conclude that the
Na,K-ATPase is possibly a player in blood pressure regulation carried
on by oleic and linoleic acids, with the unsaturation at C9 seems to be
important for this regulation. The α2 isoform of the Na,K-ATPase has
particularly been suggested to be a major player in blood pressure
regulation. Free fatty acids are expected to have similar effect on both
α1 and α2 isoforms of the pump. Indeed, cardiac sarcolemmal
2420 Y.A. Mahmmoud, S.B. Christensen / Biochimica et Biophysica Acta 1808 (2011) 2413–2420membranes, which contain both α1 and α2 isozymes, is similarly
inhibited by incubation with free fatty acids (data not shown).
5. Conclusions
We have identiﬁed oleic and linoleic acids as active modulators of
the sodium pump in N. sativa and we characterized the mechanism
whereby thesemoleculesmodify pig kidneyNa,K-ATPase. Interaction of
these fatty acids with the pump does not affect cytoplasmic Na+
interaction or the following phosphoryl transfer and conversion to the
E2 form (in the absence of K+). However, ATP interaction that leads to
K+deocclusion is abrogated, leading to the stabilization of an E2 variant.
At low ATP concentrations, transition to the E1 form, which is rate
limiting in normal Na,K-ATPase is accelerated by FFA. Our analysis
shows that the unsaturation at C9 in oleic acid is crucial for its functional
effects on Na,K-ATPase. Oleic and linoleic acids were found to have a
speciﬁc effect on ouabain interaction with the pump, which may be an
element in thebloodpressure loweringeffect of these fatty acids [10,11].
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